ZURA Class A Zura Bio Limited - Class A Ordinary shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$4.11
· of 52w range
· above low
· to high
$3.1552w low
$7.4452w high
Market Cap (MRQ)
$392M
your badges
52W Range
$3–$7
Analyst Rating
STRONG BUY
Price Target
$18
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ZURA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$4.11
Market Cap (MRQ)
$392M
52W Range
$3–$7
ZURA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ZURA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 2.0 | · | 3.0 | Undervalued |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ZURA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 12.9 | · | 12.6 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-22.2%
Next Report
Nov 11, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 19, 2026 | $-0.21 | $-0.20 | -4.4% |
| March 31, 2026 | May 7, 2026 | $-0.22 | $-0.18 | -23.9% |
| Dec. 31, 2025 | $-0.49 | $-0.20 | -144.5% | |
| Sept. 30, 2025 | $-0.21 | $-0.19 | -13.5% | |
| June 30, 2025 | $-0.17 | $-0.19 | 11.5% | |
| March 31, 2025 | $-0.19 | $-0.16 | -17.5% | |
| Dec. 31, 2024 | $-0.10 | $-0.16 | 36.8% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $109M | |
| Prepaid Expense | $3M | |
| Current Assets | $112M | |
| PP&E (Net) | $126.0K | |
| Other Non-current Assets | $2M | |
| Total Assets | $114M | |
| Accounts Payable | $1M | |
| Current Liabilities | $12M | |
| Total Liabilities | $12M | |
| Common Stock | $7.0K | |
| Paid-in Capital | $326M | |
| Retained Earnings | $-225M | |
| Stockholders' Equity | $102M | |
| Liabilities + Equity | $114M | |
| Shares Outstanding | 73,680,710 |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| R&D Expense | $21M | $15M | $9M | $10M | |
| SG&A Expense | $9M | $11M | $9M | $9M | |
| Operating Expenses | $29M | $25M | $18M | $19M | |
| Operating Income | $-29M | $-25M | $-18M | $-19M | |
| Interest Income | $2M | $1M | $2M | $2M | |
| Other Non-op | $1M | $-43.0K | $352.0K | $-5.0K | |
| Pretax Income | $-26M | $-24M | $-16M | $-17M | |
| Income Tax | $-81.0K | $0 | $0 | $0 | |
| Net Income | $-26M | $-24M | $-16M | $-17M | |
| EPS (Basic) | $-0.21 | $-0.22 | $-0.17 | $-0.19 | |
| EPS (Diluted) | $-0.21 | $-0.22 | $-0.17 | $-0.19 | |
| Shares (Basic) | 126,803,970 | 112,222,789 | 94,289,954 | 92,964,048 | |
| Shares (Diluted) | 126,803,970 | 112,222,789 | 94,289,954 | 92,964,048 | |
| EBITDA | $-29M | $-25M | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $226M | · | · | |
| Prepaid Expense | $5M | $1M | · | · | |
| Current Assets | $210M | $227M | · | · | |
| PP&E (Net) | $149.0K | $125.0K | · | · | |
| Other Non-current Assets | $3M | $2M | · | · | |
| Total Assets | $213M | $229M | · | · | |
| Accounts Payable | $3M | $2M | · | · | |
| Current Liabilities | $16M | $12M | · | · | |
| Total Liabilities | $16M | $12M | · | · | |
| Common Stock | $10.0K | $9.0K | · | · | |
| Paid-in Capital | $472M | $466M | · | · | |
| Retained Earnings | $-275M | $-249M | · | · | |
| Stockholders' Equity | $197M | $217M | · | · | |
| Liabilities + Equity | $213M | $229M | · | · | |
| Shares Outstanding | 95,422,452 | 94,880,710 | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| D&A | $-16.0K | $16.0K | · | $9.0K | |
| Stock-based Comp | $-5M | $5M | · | $4M | |
| Other Non-cash | · | $276.0K | · | · | |
| Operating Cash Flow | $19M | $-19M | · | $-11M | |
| CapEx | $-13.0K | $13.0K | · | $49.0K | |
| Investing Cash Flow | $13.0K | $-13.0K | · | $-49.0K | |
| Financing Cash Flow | $-135M | $135M | · | $5M | |
| Taxes Paid | $0 | $0 | $0 | $0 | |
| Free Cash Flow | · | $-19M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| ROA | -14.2% | -12.1% | · | · | |
| ROE | -16.3% | -13.6% | · | · | |
| ROIC | -14.8% | -11.8% | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Current Ratio | 12.9 | 19.3 | · | · | |
| Quick Ratio | 12.6 | 19.2 | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Book Value / Share | $2.07 | $2.29 | · | · | |
| Cash Flow / Share | · | $-0.17 | · | · | |
| Cash / Share | $2.15 | $2.38 | · | · | |
| EPS (TTM) | $-1.13 | $-1.09 | $-0.77 | $-0.77 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Net Income TTM | $-86M | $-75M | $-68M | $-62M | |
| Market Cap | $563M | $565M | · | · | |
| P/E | -5.2 | -5.5 | -1.4 | -1.7 | |
| P/B | 2.9 | 2.6 | · | · | |
| P / Tangible Book | 2.9 | 2.6 | · | · | |
| P / Cash Flow | · | -29.8 | · | · | |
| Earnings Yield | -19.1% | -18.3% | -73.3% | -59.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 104 filers · $433.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
104
Value held
$433.2M
New positions
28
Exited positions
22
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 28 (-4 vs prior Q) | 22 (+14 vs prior Q) | 33 (+1 vs prior Q) | 19 (-7 vs prior Q) | +6.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $55,713,706 | 9,443,001 | 12.86% | Shares |
| Venrock Adviser, LLC | $37,966,441 | 6,434,990 | 8.76% | Shares |
| MPM BIOIMPACT LLC | $26,389,774 | 4,472,843 | 6.09% | Shares |
| GREAT POINT PARTNERS LLC | $24,873,987 | 4,215,930 | 5.74% | Shares |
| JPMORGAN CHASE & CO | $24,517,046 | 4,354,715 | 5.66% | Shares |
| BRAIDWELL LP | $23,483,741 | 3,980,295 | 5.42% | Shares |
| Siren, L.L.C. | $22,035,709 | 3,734,866 | 5.09% | Shares |
| BlackRock, Inc. | $21,326,701 | 3,614,695 | 4.92% | Shares |
| Commodore Capital LP | $19,175,000 | 3,250,000 | 4.43% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $16,225,000 | 2,750,000 | 3.75% | Shares |
| Saturn V Capital Management LP | $12,396,602 | 2,101,119 | 2.86% | Shares |
| QVT Financial LP | $11,181,403 | 1,895,153 | 2.58% | Shares |
| ADAR1 Capital Management, LLC | $10,379,841 | 1,759,295 | 2.40% | Shares |
| ARMISTICE CAPITAL, LLC | $9,652,400 | 1,636,000 | 2.23% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $9,348,520 | 1,584,209 | 2.16% | Shares |
| Affinity Asset Advisors, LLC | $8,639,388 | 1,464,303 | 1.99% | Shares |
| STEMPOINT CAPITAL LP | $8,072,469 | 1,368,215 | 1.86% | Shares |
| Ikarian Capital, LLC | $7,189,102 | 1,218,492 | 1.66% | Shares |
| EcoR1 Capital, LLC | $6,960,319 | 1,179,715 | 1.61% | Shares |
| Vestal Point Capital, LP | $6,926,340 | 1,173,956 | 1.60% | Shares |
| STATE STREET CORP | $5,909,658 | 1,001,637 | 1.36% | Shares |
| Boxer Capital Management, LLC | $5,310,000 | 900,000 | 1.23% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $4,409,377 | 747,352 | 1.02% | Shares |
| GOLDMAN SACHS GROUP INC | $3,386,281 | 573,946 | 0.78% | Shares |
| FMR LLC | $3,116,876 | 528,284 | 0.72% | Shares |
| MORGAN STANLEY | $2,985,123 | 505,953 | 0.69% | Shares |
| VANGUARD GROUP INC | $2,976,938 | 568,118 | 0.69% | Shares |
| NORTHERN TRUST CORP | $2,950,507 | 500,086 | 0.68% | Shares |
| Pfizer Inc | $2,882,799 | 538,841 | 0.67% | Shares |
| Foresite Capital Management VI LLC | $2,655,000 | 450,000 | 0.61% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,404,439 | 407,532 | 0.55% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,398,055 | 406,450 | 0.55% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $2,237,144 | 379,177 | 0.52% | Shares |
| KVP Capital Advisors, LP | $2,201,455 | 373,128 | 0.51% | Shares |
| TWO SIGMA INVESTMENTS, LP | $2,070,322 | 350,902 | 0.48% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,898,042 | 321,702 | 0.44% | Shares |
| CITADEL ADVISORS LLC | $1,774,243 | 300,719 | 0.41% | Shares |
| AMERIPRISE FINANCIAL INC | $1,665,021 | 282,207 | 0.38% | Shares |
| UBS Group AG | $1,565,353 | 265,314 | 0.36% | Shares |
| Jump Financial, LLC | $1,366,440 | 231,600 | 0.32% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,028,931 | 174,395 | 0.24% | Shares |
| MILLENNIUM MANAGEMENT LLC | $812,070 | 137,639 | 0.19% | Shares |
| XTX Topco Ltd | $803,722 | 136,224 | 0.19% | Shares |
| Alberta Investment Management Corp | $785,880 | 133,200 | 0.18% | Shares |
| Nuveen, LLC | $744,604 | 126,204 | 0.17% | Shares |
| Bank of New York Mellon Corp | $733,754 | 124,365 | 0.17% | Shares |
| BARCLAYS PLC | $623,901 | 105,746 | 0.14% | Shares |
| BANK OF AMERICA CORP /DE/ | $572,495 | 97,033 | 0.13% | Shares |
| ALPS ADVISORS INC | $568,843 | 96,414 | 0.13% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $516,840 | 87,600 | 0.12% | Call option |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| AI Biotechnology LLC, Access Industries Holdings LLC, Access Industries Management, LLC, Len Blavatnik ×2 filings | March 2, 2026 | 18.20% | Amendment | · | SEC |
| Athanor Capital, UGS Capital LLC | Jan. 27, 2026 | 15.70% | Initial filing | Passive investment | SEC |
| Athanor Capital, LP, Athanor Capital GP, LLC, Athanor Master Fund, LP, Athanor Capital Partners, LP, Athanor International Master Fund, LP, Athanor International Fund GP, LP, Parvinder Thiara ×3 filings | June 22, 2023 | · | Initial filing | Passive investment | SEC |
| JATT Ventures, L.P., Someit Sidhu, MD ×2 filings | March 28, 2023 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 23 insiders · 9 officers · 13 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Sandeep Chidambar Kulkarni | Chief Executive Officer | April 1, 2026 A | · | 0 | 0 | $0 |
| Robert Lisicki | Chief Executive Officer | Feb. 27, 2025 A | · | 0 | 0 | $0 |
| Eric J Hyllengren | Chief Financial Officer | April 1, 2026 A | · | 0 | 0 | $0 |
| Verender S. Badial | Chief Financial Officer | May 8, 2025 A | · | 0 | 0 | $0 |
| Kiran Nistala | Officer | April 1, 2026 A | 3,195 | 0 | 0 | $0 |
| Gary Whale | Chief Technology Officer | April 1, 2026 A | · | 0 | 0 | $0 |
| Kimberly Ann Davis | Chief Legal Officer | April 1, 2026 A | 1,500 | 0 | 0 | $0 |
| Michael Howell | Officer | April 22, 2024 A | 7,987 | 0 | 0 | $0 |
| Christopher Cabell | CMO & Head of R&D | May 18, 2023 A | 162,060 | 0 | 0 | $0 |
| Ajay Nirula | Director | June 17, 2026 A | · | 0 | 0 | $0 |
| Parvinder Thiara | Director | June 17, 2026 A | 0 | 0 | 0 | $0 |
| Steven J Schoch | Director | June 17, 2026 A | · | 0 | 0 | $0 |
| Mark Eisner | Director | June 17, 2026 A | · | 0 | 0 | $0 |
| Daniel J. Becker | Director | June 17, 2026 A | · | 0 | 0 | $0 |
| Jennifer Jarrett | Director | June 17, 2026 A | · | 0 | 0 | $0 |
| Amit Munshi | Director | June 17, 2026 A | 777,384 | 0 | 0 | $0 |
| Neil Murray Hamilton Graham | Director | May 21, 2025 A | · | 0 | 0 | $0 |
| Van Amstel Arnout Ploos | Director | May 21, 2025 A | 100,000 | 0 | 0 | $0 |
| Someit Sidhu | Director | May 21, 2025 A | 2,085,418 | 0 | 0 | $0 |
| Garry Arthur Neil | Director | May 18, 2023 A | · | 0 | 0 | $0 |
| Athanor Capital, LP | 10% owner | June 15, 2023 S | · | 0 | 0 | $0 |
| JATT Ventures, L.P. | 10% owner | Feb. 10, 2023 J | 967,370 | 0 | 0 | $0 |
| BARCLAYS PLC | 10% owner | Jan. 9, 2023 | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 8 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.07% | 199,471 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.02% | 553,624 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 63,547 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 1,494,389 SH | Sept. 11, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 28,064 NS | July 31, 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 338,960 SH | Aug. 19, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 747,352 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5,025 SH | Aug. 19, 2026 | Daily |
ZURA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 14 analysts
BUY
Median target
$18.00
+338.0%
7 50.0%
Strong Buy
6 42.9%
Buy
1 7.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
6 analysts · 2026-10-01Mean target $18.00 +338.0%
← Below all targets
Current price $4.11
Low$11.00
Mean$18.00
High$26.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ZURA | · | · | · | · | · | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | · |
| ALT | $400M | -3.6 | 105.0% | -214861.0% | -45.6% | · |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
| MNPR | · | · | · | · | · | · |
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| ALLO | $314M | -1.6 | -76.8% | · | -59.9% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026